Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0001209191-23-026727

Options or other derivatives

  • Director acquired 150,437 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
McBride John S. Director 2023-05-01 Grant or award · Stock Option (right to buy) +150,437 150,437 D
Loading xslF345X04/doc4.xml…